Literature DB >> 11343934

Iliac crest biopsy versus rib segment resection for the detection of bone marrow isolated tumor cells from lung and esophageal cancer.

S Mattioli1, F D'Ovidio, P Tazzari, V Pilotti, N Daddi, G Bandini, M Piccioli, S Pileri.   

Abstract

OBJECTIVE: The presence of isolated tumor cells in the bone marrow affects the prognosis of both esophageal cancer and non-small cell lung cancer (NSCLC). Therefore, preoperative assessment of isolated tumor cells may be useful to plan multimodality treatment. Rib segment resection at surgery provides adequate amounts of bone marrow for the detection of isolated tumor cells while bone marrow aspirate from the iliac crest does not. The iliac crest biopsy according to the Jamshidi technique procures a core of tissue apt for histology and not simply for cytology. The aim of this study was to compare the accuracy of iliac crest biopsy versus rib segment resection in the diagnosis of isolated tumor cells in order to obtain a useful preoperative approach.
MATERIAL AND METHODS: Twenty-one consecutive patients (18 NSCLC, three esophageal cancer) were evaluated. None had chemotherapy prior to evaluation. Bone marrow was obtained preoperatively by iliac crest biopsy using the Jamshidi needle and at surgery by rib segment resection. Positive cytokeratin neoplastic cells were searched by immunohistochemistry on tissue sections from the iliac crest biopsies and by flow cytometry on cell suspensions from the rib segments.
RESULTS: Isolated tumor cells were detected in the rib segments of ten patients. In all cases the Jamshidi needle biopsy was not diagnostic.
CONCLUSION: Our results suggest that, if the diagnosis of bone marrow isolated tumor cells has clinical relevance, the preoperative assessment should be performed by rib segment resection or methods other than iliac crest aspirate or biopsy. Further investigation is needed to determine whether isolated tumor cells have a preferential spread to chest bones other than distant bone sites.

Entities:  

Mesh:

Year:  2001        PMID: 11343934     DOI: 10.1016/s1010-7940(01)00652-2

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

Review 1.  Multimodality therapy for gastroesophageal cancers.

Authors:  Kenneth K Wang
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

2.  Micrometastasis in non-small-cell lung cancer: Detection and staging.

Authors:  Gholamreza Mohajeri; Mohammad Hossein Sanei; Sayyed Abbas Tabatabaee; Sayyed Mozaffar Hashemi; Elham Amjad; Mohammad Reza Mohajeri; Hamid Shemshaki; Amir Hosein Davarpanah Jazi; Mohsen Kolahdouzan
Journal:  Ann Thorac Med       Date:  2012-07       Impact factor: 2.219

3.  The effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patients.

Authors:  P Kolodziejczyk; A Pituch-Noworolska; G Drabik; J Kulig; A Szczepanik; M Sierzega; A Gurda; T Popiela; M Zembala
Journal:  Br J Cancer       Date:  2007-08-14       Impact factor: 7.640

4.  Lymph Node and Bone Marrow Micrometastases Define the Prognosis of Patients with pN0 Esophageal Cancer.

Authors:  Karl-F Karstens; Tarik Ghadban; Katharina Effenberger; Guido Sauter; Klaus Pantel; Jakob R Izbicki; Yogesh Vashist; Alexandra König; Matthias Reeh
Journal:  Cancers (Basel)       Date:  2020-03-04       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.